What Is BPC-157?
July 8, 2026
Introduction
Peptides play an essential role in modern biochemistry and molecular biology research environments, providing vital tools for illuminating complex cellular mechanisms. Of the many synthetic peptides employed as tools in laboratory research environments, Bremelanotide or its chemical nomenclature, PT-141 has garnered particular interest as an instrument to explore receptor-ligand interactions, signal transduction cascades, structural biochemistry as well as molecular dynamics.
This educational guide offers an in-depth scientific analysis of PT-141. It describes its chemical makeup, discovery history, storage requirements and laboratory handling protocols - providing life science researchers and laboratory professionals a definitive reference source.
What Is PT-141 Peptide (Bremelanotide)?
PT-141 (Bremelanotide) is a synthetic cyclic amino acid peptide designed for laboratory research applications that functions as an antagonist to melanocortin receptors. Intended primarily as an experimental research compound, its primary applications lie within biochemistry and experimental pharmacology in order to study receptor-mediated cell signaling pathways.
Key Takeaways
Before delving into the specific biochemical properties of PT-141, the following core scientific attributes highlight its significance in laboratory research:
Melanocortin Receptor Agonist: Functions primarily by binding to and activating specific melanocortin receptors (MC3R and MC4R) in the central nervous system.
Cyclic Peptide Structure: Features a cyclic conformation that enhances structural stability and alters binding affinity compared to linear counterparts.
Lyophilized Format: Typically processed into a freeze-dried state to preserve structural integrity, prolong shelf-life, and resist degradation during transit.
Strict Laboratory Utility: Investigated strictly within in vitro and in vivo experimental models to understand fundamental receptor pharmacology.
What Is PT-141 Peptide?
Definition and Classification
PT-141 is a synthetic analogue of melanocortin hormones found naturally. While endogenous linear peptides exist, PT-141 falls into the category of synthetic cyclic peptides due to covalent linking of specific amino acid residues within its sequence, creating a ring structure with significant effects on chemical properties and binding kinetics.
Scientific Terminology and Nomenclature
Within peer-reviewed literature and chemical databases, PT-141 is often identified by its formal chemical name Bremelanotide. From a structural viewpoint, Bremelanotide is an acetylated, cyclic heptapeptide with an amino acid sequence designed to mimic that found in melanocyte-stimulating hormones (MSHs), thus making direct interaction possible between its receptor systems and melanocortin receptor systems.
Receptor Interaction Profile
In experimental pharmacology, PT-141 is classified as a non-selective melanocortin receptor agonist; it exhibits varying binding affinities for multiple melanocortin receptor subtypes and is capable of activating several receptors within this family, with its activity being most pronounced at subtypes 9 through 13.
- MC3R (Melanocortin 3 Receptor): Associates with energy homeostasis and metabolic regulation pathways.
- MC4R (Melanocortin 4 Receptor): Extensively researched due to its role in regulating energy balance, autonomic pathways and downstream neurochemical signals.
- MC1R and MC5R: Both display lower binding affinities than others but remain effective tools in mapping global receptor cross-reactivity profiles.
Scientific History and Discovery
Melanotan II's Evolution
PT-141's discovery history is tightly interwoven with that of melanocortin receptor chemistry research. University researchers first synthesized Melanotan II (MT-II), to examine its impact on melanin production and pigment biology during the late 20th century.
Researchers conducting routine laboratory evaluations observed that MT-II caused specific central nervous system responses independent of melanogenesis (pigmentation). This suggested it interacted with distinct central receptor pathways.
Structural Refining and Cyclic Synthesis
In order to differentiate central nervous system signaling pathways from skin pigmentation mechanisms, chemical engineers used molecular modification on MT-II. By eliminating specific functional groups and synthesizing a purified cyclic derivative derivative, scientists were able to successfully isolate Bremelanotide (PT-141).
The table below contrasts the fundamental chemical characteristics of endogenous α-MSH with the synthetic variant PT-141:
Characteristic | Endogenous α-MSH | Synthetic PT-141 (Bremelanotide) |
Structure | Linear Peptide | Cyclic Heptapeptide |
Molecular Conformation | Highly Flexible | Rigid, Constrained Ring Structure |
Primary Target Receptors | MC1R, MC3R, MC4R, MC5R | Selectively targets $MC3R$ and $MC4R$ with higher specificity |
Metabolic Stability | Low (Rapidly degraded by proteases) | Enhanced (Resistant to enzymatic cleavage) |
Molecular Structure and Formula
The structural rigidity of PT-141 is a key factor in its receptor affinity profile. The chemical formula for Bremelanotide is expressed as:
C50H68N14O10
The cyclic bond restricts the conformational freedom of the peptide chain. This restriction decreases the entropic penalty typically associated with receptor binding, resulting in a stable and repeatable ligand-receptor interaction during laboratory experiments.
Why Researchers Study PT-141
The primary objective of PT-141 research is to elucidate the complex downstream intracellular pathways triggered by melanocortin receptor activation. Because these receptors are widely distributed throughout both the central and peripheral nervous systems, PT-141 serves as an important scientific model in several core research areas:
1. Molecular Biology and Cell Signaling
Researchers utilize PT-141 to monitor intracellular signaling cascades. When PT-141 binds to the G-protein coupled melanocortin receptors (GPCRs), it stimulates the activation of adenylyl cyclase. This activation leads to a measurable increase in intracellular cyclic adenosine monophosphate (cAMP). Tracking these fluctuations helps scientists map how extracellular signals translate into precise cellular responses.
2. Experimental Pharmacology and Neurochemistry
Because PT-141 bypasses peripheral vascular mechanisms and acts directly on central receptors, neuroscientists use the peptide to map neuronal pathways in the hypothalamus. This research helps clarify how central signals influence downstream physiological responses, independent of direct localized tissue stimulation.
3. Structural Peptide Chemistry
The cyclic architecture of Bremelanotide serves as an excellent reference model for studying peptide stability and structural modifications. Scientists analyze how the constrained ring structure protects the peptide from rapid enzymatic degradation, providing valuable data that can be applied to designing other synthetic biomolecules.
Lyophilized PT-141: Principles of Stabilization
Commercial life science research supply chains generally distribute PT-141 as a lyophilized peptide. Therefore, understanding its science behind its production is integral for maintaining experimental accuracy.
The Lyophilization Process
Lyophilization, also known as freeze-drying, is a low-temperature dehydration process. This involves freezing the product, lowering surrounding pressure, and adding heat in order for any frozen water content within it to migrate directly from solid phase into gas phase.
Advantages of Lyophilization in the Laboratory
- Prevention of Hydrolysis: Peptides in an aqueous solution are highly susceptible to hydrolysis—a chemical reaction where water molecules break down peptide bonds, leading to rapid degradation. Removing water isolates the peptide backbone from this degradative pathway.
- Thermal Resilience: While liquid proteins tend to degrade quickly at room temperature, lyophilized powders boast greatly enhanced thermal resilience that enables them to maintain structural integrity under standard laboratory shipping conditions.
- Long-Term Structural Preservation: Lyophilization helps preserve the native three-dimensional conformation of synthetic peptides, so when introduced into an experimental medium they remain fully functional receptor-binding regions.
Common Laboratory Product Specifications
When purchasing synthetic peptides for scientific research, their quantities are distributed standardized and verified to allow for precise experimental design.
Labeled Quantities and Inventory Control
Research laboratories often utilize formats like the PT-141 10mg vials for labeled quantities and inventory control. Each vial holds precisely 10 mg of Bremelanotide cake or powder in ultrapure form.
Purpose of Standardized Formats
- Precise Concentration Calculations: By employing a 10mg mass standardization mass, laboratory technicians can make precise molarity calculations when adding solvent or buffer solutions into solutions.
- Inventory Control: Standardized aliquots can help researchers to reduce waste and the risk of cross-contamination by permitting them to use only what is necessary for an experiment series.
- Batch Consistency: High-quality research suppliers offer Certificates of Analysis (CoAs) for each 10mg format they sell, attesting the purity levels achieved through mass spectrometry and high-performance liquid chromatography (HPLC) analysis that must exceed 98% purity levels.
Storage and Stability Protocols
In order to preserve the structural integrity and ensure reproducible experimental results with PT-141, laboratory storage protocols must adhere strictly. Deviations from these standards could result in denaturation, oxidation or even the breakdown of its cyclic ring structure resulting in denaturation or fragmentation of its functional group(s).
Environmental Variables Affecting Degradation
- Temperature: High temperatures can accelerate kinetic energy, increasing the chance that peptide bonds break or rearrange themselves.
- Moisture Exposure: Exposure to ambient humidity may initiate early hydrolysis in lyophilized powders, altering their structural integrity before testing can commence.
- Light and UV Exposure: Ultraviolet radiation has the capacity to induce photooxidation across amino acid residues containing aromatic rings or sulfur atoms, leading to altered molecular structures and possibly leading to photo-oxidation reactions.
Standardized Laboratory Storage Guidelines
Storage State | Recommended Temperature | Maximum Viable Duration | Special Handling Instructions |
Long-Term (Lyophilized) | -20℃ to -80℃ | Up to 24 Months | Store in a manual defrost freezer to prevent temperature fluctuations. |
Short-Term (Lyophilized) | 2℃ to 8℃ | 1 to 3 Months | Keep stored in a desiccated container to avoid moisture condensation. |
Post-Reconstitution | 2℃ to 8℃ | 7 to 14 Days | Avoid all mechanical agitation or shaking; handle with care. |
Frequently Asked Questions (FAQs)
Conclusion
PT-141 (Bremelanotide) remains a foundational tool in the study of melanocortin receptor systems. Its distinct cyclic structural design offers unique stability advantages over traditional linear peptides, making it an excellent candidate for evaluating receptor binding, intracellular signaling pathways, and neurochemical networks. By maintaining strict adherence to proper temperature controls, minimizing moisture exposure, and utilizing standardized quantities like the 10mg laboratory format, researchers can ensure experimental precision and advance scientific understanding within biochemistry and pharmacology.
Disclaimer: This article is intended exclusively for educational, scientific, and laboratory research purposes. PT-141 is a chemical substance meant solely for in vitro and in vivo laboratory experimentation and must not be used for human consumption, medical diagnostics, or therapeutic applications.
References
- Safarinejad, M. R., & Hosseini, S. Y. (2008). Salvage of sildenafil failures with bremelanotide: A randomized, double-blind, placebo controlled study. Journal of Urology, 179(3), 1066-1071.
- Wessells, H., Fuciarelli, K., Hansen, J., Hadley, M. E., Hruby, V. J., Dorr, R., & Levine, N. (1998). Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: Double-blind, placebo controlled crossover study. Journal of Urology, 160(2), 389-393.
- Pfaus, J. G., Sadiq, A., Spana, C., & Clayton, A. H. (2021). The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. CNS Spectrums, 27(3), 281-289.
